Next Article in Journal
The Effects of Paclitaxel and Metformin and Combined Treatments on TLR Signaling Pathway on MDA-MB-231 Breast Cancer Cell Lines
Previous Article in Journal
Characterization of Cycloartane-Type Sapogenol Derivatives for Prostate Cancer Chemoprevention
Article Menu
Issue 10 (NPCPT 2017) cover image

Export Article

Open AccessAbstract
Proceedings 2017, 1(10), 982;

Natural Products for Cancer Prevention and Therapy: Progress, Pitfalls and Promise

Department of Pharmaceutical Sciences, College of Pharmacy, Larkin University, Miami, FL 33169, USA
Presented at the 2nd International Conference on Natural Products for Cancer Prevention and Therapy, Kayseri, Turkey, 8–11 November 2017.
Published: 15 November 2017
PDF [115 KB, uploaded 15 November 2017]


Natural products represent a valuable resource for discovery and development of anticancer drugs. About 80% of drugs approved by the United States Food and Drug Administration during the last three decades for cancer therapy are either natural products per se or are based on, or mimicked natural products. Various extracts, fractions, mixtures and pure compounds from dietary sources, medicinal plants and marine organisms have been found to exhibit potent antiproliferative and cytotoxic activities against numerous cancer cell lines. These agents have also been tested for cancer preventive and therapeutic efficacies using preclinical animal cancer models that resemble human disease. Selected natural products have also entered into clinical studies. The cancer preventive and anticancer attributes of various natural products can be explained by multiple cellular and molecular mechanisms, including scavenging of free radicals, detoxification of carcinogens, DNA repair, alteration of cell cycles, programmed cell death (apoptosis), autophagy, immune surveillance, anti-inflammatory, anti-angiogenic, anti-invasive and antimetastatic activities as well as their ability to modulate a plethora of dysregulated oncogenic signaling pathways. This presentation aims to highlight studies on cancer preventive and therapeutic attributes of various naturally occurring agents and underlying mechanisms of action, with special emphasis on results reported from our laboratory. Current limitations, challenges, and future directions of research for successful cancer drug development based on natural products will also be discussed.
Keywords: cancer; chemoprevention; therapy; resveratrol; anthocyanins; triterpenoids cancer; chemoprevention; therapy; resveratrol; anthocyanins; triterpenoids
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Bishayee, A. Natural Products for Cancer Prevention and Therapy: Progress, Pitfalls and Promise. Proceedings 2017, 1, 982.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Metrics

Article Access Statistics



[Return to top]
Proceedings EISSN 2504-3900 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top